LPCN Latest Press Releases

-- August 4, 2026 --

Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2026 PRNewswire 8:00 AM

-- August 3, 2026 --

Lipocine Appoints Michael J. Grissinger to Board of Directors PRNewswire 8:00 AM

-- June 4, 2026 --

Lipocine Inc. to Host Virtual KOL Event Highlighting Unmet Needs in Postpartum Depression and the Clinical Profile of LPCN 1154 PRNewswire 8:00 AM

-- May 19, 2026 --

Lipocine Announces LPCN 1154 Phase 3 Data Accepted for Oral Presentation at 2026 ASCP Annual Meeting PRNewswire 8:00 AM

Anaveon Strengthens Leadership Team with Appointments of Eric Zanelli as Chief Scientific Officer and Jill Jene as Chief Business Officer Globe Newswire 4:00 AM

-- May 18, 2026 --

Lipocine to Present at A.G.P.'s Annual Virtual Healthcare Company Showcase PRNewswire 8:00 AM

-- May 7, 2026 --

Lipocine Announces Financial Results for the First Quarter Ended March 31, 2026 PRNewswire 4:05 PM

-- April 6, 2026 --

Lipocine Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses Globe Newswire 7:56 AM

-- April 2, 2026 --

Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression PRNewswire 8:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software